Healthcare -
Biotechnology - NASDAQ - US
$ 9.02
2.85 %
$ 446 M
Market Cap
-2.45
P/E
KALV - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity KALV - KalVista Pharmaceuticals, Inc.
235 M
LAST VALUE
7.45%
2 YEAR CAGR
14.79%
5 YEAR CAGR
37.00%
10 YEAR CAGR